Latest News

Soy didn’t up all-cause mortality in breast cancer survivors

Publish date: January 12, 2019

 

REPORTING FROM NAMS 2018


Pages

Recommended Reading

PI3K inhibitor/fulvestrant has modest benefit, serious toxicity in breast cancer
MDedge Family Medicine
Dr. William J. Gradishar shares breast cancer take-aways from ASCO 2018
MDedge Family Medicine
TAILORx marks major advance for precision medicine in breast cancer
MDedge Family Medicine
Top cancer researcher fails to disclose corporate financial ties in major research journals
MDedge Family Medicine
Breast cancer risk in type 2 diabetes related to adiposity
MDedge Family Medicine
Tech-based cancer company raises access concerns
MDedge Family Medicine
QOL is poorer for young women after mastectomy than BCS
MDedge Family Medicine
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
MDedge Family Medicine
Poor-prognosis cancers linked to highest suicide risk in first year
MDedge Family Medicine
Daily News Special: SABCS
MDedge Family Medicine